Evidence map›Paper›PMID 33807952›Full record

ArticleInternational journal of environmental research and public health2021

Digital Health Transition in Rheumatology: A Qualitative Study.

Felix Mühlensiepen, Sandra Kurkowski, Martin Krusche, Johanna Mucke, Robert Prill, Martin Heinze, Martin Welcker, Hendrik Schulze-Koops, Nicolas Vuillerme, Georg Schett and 1 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Felix MühlensiepenCenter for Health Services Research, Brandenburg Medical School Theodor Fontane, 15562 Rüdersdorf, Germany.ORCID 0000-0001-8571-7286
Sandra KurkowskiDepartment of Palliative Medicine, CCC Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.ORCID 0000-0001-8787-236X
Martin KruscheRheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0002-0582-7790
Johanna MuckePoliclinic and Hiller Research Unit for Rheumatology, Heinrich-Heine-University, 40225 Duesseldorf, Germany.
Robert PrillFaculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, 14476 Potsdam, Germany.ORCID 0000-0002-4916-1206
Martin HeinzeCenter for Health Services Research, Brandenburg Medical School Theodor Fontane, 15562 Rüdersdorf, Germany.
Martin WelckerMedizinisches Versorgungszentrum für Rheumatologie Dr. M. Welcker GmbH, 82152 Planegg, Germany.ORCID 0000-0002-1856-3085
Hendrik Schulze-KoopsDivision of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.ORCID 0000-0002-1681-491X
Nicolas VuillermeAGEIS, Faculty of Medicine, Université Grenoble Alpes, 38706 Grenoble, France.ORCID 0000-0003-3773-393X
Georg SchettDepartment of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Johannes KnitzaAGEIS, Faculty of Medicine, Université Grenoble Alpes, 38706 Grenoble, France.ORCID 0000-0001-9695-0657

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global COVID-19 pandemic has led to drastic changes in the management of patients with rheumatic diseases. Due to the imminent risk of infection, monitoring intervals of rheumatic patients have prolonged. The aim of this study is to present insights from patients, rheumatologists, and digital product developers on the ongoing digital health transition in rheumatology. A qualitative and participatory semi-structured fishbowl approach was conducted to gain detailed insights from a total of 476 participants. The main findings show that digital health and remote care are generally welcomed by the participants. Five key themes emerged from the qualitative content analysis: (1) digital rheumatology use cases, (2) user descriptions, (3) adaptation to different environments of rheumatology care, and (4) potentials of and (5) barriers to digital rheumatology implementation. Codes were scaled by positive and negative ratings as well as on micro, meso, and macro levels. A main recommendation resulting from the insights is that both patients and rheumatologists need more information and education to successfully implement digital health tools into clinical routine.

Indexed as

COVID-19RheumatologyTelemedicineHealth TransitionHumansPandemicsQualitative ResearchSARS-CoV-2chronic diseasecontent analysisdigital healtheHealthfishbowl discussionpatient perspectivequalitative researchremote carerheumatologytelemedicine

Identifiers

PMID33807952
PMCPMC7967307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.